Use access key #2 to skip to page content.
$15.55 -1.26 (-7.50%)
12/1/2008 4:01 PM

Schering-Plough Corp (SGP)

CAPS Rating:
****

The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.

View Ticker Page (SGP)

Results 71 - 80 of 156 : « Previous   678910Next »

Recs

0

Avatar dpid (< 20) Submitted: 11/19/08 4:46 PM : Outperform Start Price: $15.26 SGP Score: -0.57

drugs + dividends

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar JonBarleycorn (59.97) Submitted: 11/27/08 1:11 AM : Outperform Start Price: $16.37 SGP Score: 2.26

T = 1030 /60
A = 198 /14

Bottom fishing.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar nikkobear (< 20) Submitted: 7/09/08 5:11 PM : Outperform Start Price: $21.55 SGP Score: 6.17

people will always need meds to cure them

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar cwlawrence (< 20) Submitted: 7/08/08 8:00 PM : Outperform Start Price: $20.59 SGP Score: 11.13

Big Pharmaceuticals are due for a comeback

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar cmconey08 (< 20) Submitted: 6/17/08 12:59 PM : Outperform Start Price: $19.35 SGP Score: 19.91

I see this stock on the current decline but as for the long term this stock will start to pickup in a five year period. Look for the upside after the downside.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar lexif (< 20) Submitted: 4/27/08 7:55 PM : Outperform Start Price: $18.47 SGP Score: 25.46

Solid company with an exciting new drug, (suggamadex) that is fda approved and will be released shortly. This drug is a significant development in the field of Anesthesia and should lead to significant upside earnings potential.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar dhood5445 (< 20) Submitted: 4/30/08 2:20 PM : Outperform Start Price: $18.32 SGP Score: 26.35

SGP posted strong first quarter earnings despite the problems with the vytorin, zeita and the enhance trial products. Internationally there has been growth supporting the idea that only the US market will be problematic. A bit of a risk, but isn't e...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar deuspecuniae (73.97) Submitted: 5/01/08 12:11 PM : Outperform Start Price: $18.58 SGP Score: 24.86

The looming recession that bernanke and the whole federal reserve gang have set this country towards will send alot of investors into the pharmaceutical's sector--being the traditional recessionary savior to say the least. Plus, most pharmaceutical s...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar Colli002 (20.30) Submitted: 5/02/08 7:06 AM : Outperform Start Price: $18.85 SGP Score: 24.35

Value Play

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar NJStockGuru (85.90) Submitted: 5/05/08 5:32 PM : Outperform Start Price: $18.79 SGP Score: 24.14

Schering-Plough is a top notch company in Big Pharma that was unfairly crucified by the Enhanced study. Vytorin does what it is intended to do - lower cholesterol. They took the results out of context. Furthermore, with their recent acquisitions of O...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links